The ruling cleared the way for the drug, Subsys, to be sold to Wyoming-based BTcP Pharma LLC, which belongs to the MMB Healthcare network of pharmaceutical companies. In exchange, Insys will receive royalties it estimated could reach $20 million. INSYQ Stock Quote - Insys Therapeutics Inc - Bloomberg Markets Insys Therapeutics, Inc. develops cancer support drugs. The Company support care candidates include a fast-acting sublingual spray for cancer pain and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients. Address. Insys Therapeutics - INSY - Stock Price & News | The ... Here's Why Marijuana Stock Insys Therapeutics Rose 11% in June. It's a non-marijuana-based drug that has investors excited this time.
Insys Therapeutics (INSYQ) was declared worthless after the company's bankruptcy. Sibanye-Stillwater (SBGL) performed a ticker change to SBSW. February 21,
HCL Infosystems Limited. |. Series: EQ. Symbol: HCL-INSYS; ISIN: INE236A01020; Status: Listed; EQ; Market Tracker. Symbol P/E: 0; Sectoral Index P/E: 16.33 INSYS Therapeutics stock price history + stock price today + stock chart + in the company name or stock symbol in the search bar at the top right of any page. Current Trading Halts. Apr 6, 2020. Halt times displayed are Eastern Time (ET). Halt Date, Halt Time, Issue Symbol, Issue Name, Market, Reason Codes, Pause Insys Therapeutics (INSYQ) was declared worthless after the company's bankruptcy. Sibanye-Stillwater (SBGL) performed a ticker change to SBSW. February 21,
INSY - TheStreet
STOCK QUOTE | Insys Therapeutics Inc The Investor Relations website contains information about Insys Therapeutics Inc's business for stockholders, potential investors, and financial analysts.